NCT02118532 - The IN.PACT SFA Clinical Study for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery and/or Proximal Popliteal Artery Using the IN.PACT Admiral™ Drug-Eluting Balloon in a Chinese Patient Population | Biotech Hunter

Enrollment

143

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

August 31, 2016

Study Completion Date

September 30, 2016

Conditions

Atherosclerosis

Interventions

DEVICE

IN.PACT Admiral Paclitaxel-Eluting Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter

IN.PACT Admiral Paclitaxel-Eluting Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter originally developed, approved and commercialized by Invatec Technology Center GmbH is the investigational medical device used in the study. Medtronic Inc. acquired Invatec on April 21, 2010. Medtronic

Trial Locations (15)

200011

Shanghai 9th People Hospital Affiliated Shanghai Jiao Tong University School of Medecine, Shanghai

400016

The First Affiliated Hospital of Chongqing Medical University, Chongqing

610041

West China Hospital, Chengdu

Unknown

301 Hospital/Chinese PLA General Hospital, Beijing

Anzhen Hospital, Capital Medical University, Beijing

Peking University First Hospital, Beijing

Xuanwu Hospital, Capital Medical University, Beijing

The First Affiliated Hospital, Dalian Medical University, Dalian

The First Affiliated Hospital of Fujian Medical University, Fuzhou

The 1stAffiliated Hospital of Sun Yat-sen University, Guangzhou

The 2nd Affiliated Hospital of Harbin Medical University, Harbin

The first affiliated Hospital of Harbin Medical University, Harbin

Nanjing Drum Tower Hospital, Nanjing

Zhongshan Hospital, Fudan University, Shanghai

Shengjing Hospital of China Medical University, Shenyang